Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Injectable Drug Delivery Devices Market

ID: MRFR/MED/0704-CR
164 Pages
Nidhi Mandole
Last Updated: March 26, 2026

Injectable drug delivery Market Research Report: Size, Share, Trend Analysis By Devices (Conventional Injection Devices, Self-Injection Devices), By Therapeutic Application (Autoimmune Diseases, Hormonal Disorders and Cancer) By Usage Pattern (Curative pattern, Immunization), By Site of Delivery (Intramuscular, Subcutaneous, Intra Dermal), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Injectable Drug Delivery Devices Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Device (USD Billion) | |
      1. 4.1.1 Conventional Injection Devices | |
      2. 4.1.2 Self-Injection Devices |
    2. 4.2 Healthcare, BY Therapeutic Application (USD Billion) | |
      1. 4.2.1 Autoimmune Diseases | |
      2. 4.2.2 Hormonal Disorders and Cancer |
    3. 4.3 Healthcare, BY Usage Pattern (USD Billion) | |
      1. 4.3.1 Curative Pattern | |
      2. 4.3.2 Immunization |
    4. 4.4 Healthcare, BY Site of Delivery (USD Billion) | |
      1. 4.4.1 Intramuscular | |
      2. 4.4.2 Subcutaneous | |
      3. 4.4.3 Intradermal |
    5. 4.5 Healthcare, BY Region (USD Billion) | |
      1. 4.5.1 North America | | |
        1. 4.5.1.1 US | | |
        2. 4.5.1.2 Canada | |
      2. 4.5.2 Europe | | |
        1. 4.5.2.1 Germany | | |
        2. 4.5.2.2 UK | | |
        3. 4.5.2.3 France | | |
        4. 4.5.2.4 Russia | | |
        5. 4.5.2.5 Italy | | |
        6. 4.5.2.6 Spain | | |
        7. 4.5.2.7 Rest of Europe | |
      3. 4.5.3 APAC | | |
        1. 4.5.3.1 China | | |
        2. 4.5.3.2 India | | |
        3. 4.5.3.3 Japan | | |
        4. 4.5.3.4 South Korea | | |
        5. 4.5.3.5 Malaysia | | |
        6. 4.5.3.6 Thailand | | |
        7. 4.5.3.7 Indonesia | | |
        8. 4.5.3.8 Rest of APAC | |
      4. 4.5.4 South America | | |
        1. 4.5.4.1 Brazil | | |
        2. 4.5.4.2 Mexico | | |
        3. 4.5.4.3 Argentina | | |
        4. 4.5.4.4 Rest of South America | |
      5. 4.5.5 MEA | | |
        1. 4.5.5.1 GCC Countries | | |
        2. 4.5.5.2 South Africa | | |
        3. 4.5.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 AbbVie (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Bristol-Myers Squibb (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Pfizer (US) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Roche (CH) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Sanofi (FR) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Merck & Co. (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Amgen (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Johnson & Johnson (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Novartis (CH) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY DEVICE |
    7. 6.4 US MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    8. 6.5 US MARKET ANALYSIS BY USAGE PATTERN |
    9. 6.6 US MARKET ANALYSIS BY SITE OF DELIVERY |
    10. 6.7 CANADA MARKET ANALYSIS BY DEVICE |
    11. 6.8 CANADA MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    12. 6.9 CANADA MARKET ANALYSIS BY USAGE PATTERN |
    13. 6.10 CANADA MARKET ANALYSIS BY SITE OF DELIVERY |
    14. 6.11 EUROPE MARKET ANALYSIS |
    15. 6.12 GERMANY MARKET ANALYSIS BY DEVICE |
    16. 6.13 GERMANY MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    17. 6.14 GERMANY MARKET ANALYSIS BY USAGE PATTERN |
    18. 6.15 GERMANY MARKET ANALYSIS BY SITE OF DELIVERY |
    19. 6.16 UK MARKET ANALYSIS BY DEVICE |
    20. 6.17 UK MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    21. 6.18 UK MARKET ANALYSIS BY USAGE PATTERN |
    22. 6.19 UK MARKET ANALYSIS BY SITE OF DELIVERY |
    23. 6.20 FRANCE MARKET ANALYSIS BY DEVICE |
    24. 6.21 FRANCE MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    25. 6.22 FRANCE MARKET ANALYSIS BY USAGE PATTERN |
    26. 6.23 FRANCE MARKET ANALYSIS BY SITE OF DELIVERY |
    27. 6.24 RUSSIA MARKET ANALYSIS BY DEVICE |
    28. 6.25 RUSSIA MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    29. 6.26 RUSSIA MARKET ANALYSIS BY USAGE PATTERN |
    30. 6.27 RUSSIA MARKET ANALYSIS BY SITE OF DELIVERY |
    31. 6.28 ITALY MARKET ANALYSIS BY DEVICE |
    32. 6.29 ITALY MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    33. 6.30 ITALY MARKET ANALYSIS BY USAGE PATTERN |
    34. 6.31 ITALY MARKET ANALYSIS BY SITE OF DELIVERY |
    35. 6.32 SPAIN MARKET ANALYSIS BY DEVICE |
    36. 6.33 SPAIN MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    37. 6.34 SPAIN MARKET ANALYSIS BY USAGE PATTERN |
    38. 6.35 SPAIN MARKET ANALYSIS BY SITE OF DELIVERY |
    39. 6.36 REST OF EUROPE MARKET ANALYSIS BY DEVICE |
    40. 6.37 REST OF EUROPE MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    41. 6.38 REST OF EUROPE MARKET ANALYSIS BY USAGE PATTERN |
    42. 6.39 REST OF EUROPE MARKET ANALYSIS BY SITE OF DELIVERY |
    43. 6.40 APAC MARKET ANALYSIS |
    44. 6.41 CHINA MARKET ANALYSIS BY DEVICE |
    45. 6.42 CHINA MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    46. 6.43 CHINA MARKET ANALYSIS BY USAGE PATTERN |
    47. 6.44 CHINA MARKET ANALYSIS BY SITE OF DELIVERY |
    48. 6.45 INDIA MARKET ANALYSIS BY DEVICE |
    49. 6.46 INDIA MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    50. 6.47 INDIA MARKET ANALYSIS BY USAGE PATTERN |
    51. 6.48 INDIA MARKET ANALYSIS BY SITE OF DELIVERY |
    52. 6.49 JAPAN MARKET ANALYSIS BY DEVICE |
    53. 6.50 JAPAN MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    54. 6.51 JAPAN MARKET ANALYSIS BY USAGE PATTERN |
    55. 6.52 JAPAN MARKET ANALYSIS BY SITE OF DELIVERY |
    56. 6.53 SOUTH KOREA MARKET ANALYSIS BY DEVICE |
    57. 6.54 SOUTH KOREA MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    58. 6.55 SOUTH KOREA MARKET ANALYSIS BY USAGE PATTERN |
    59. 6.56 SOUTH KOREA MARKET ANALYSIS BY SITE OF DELIVERY |
    60. 6.57 MALAYSIA MARKET ANALYSIS BY DEVICE |
    61. 6.58 MALAYSIA MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    62. 6.59 MALAYSIA MARKET ANALYSIS BY USAGE PATTERN |
    63. 6.60 MALAYSIA MARKET ANALYSIS BY SITE OF DELIVERY |
    64. 6.61 THAILAND MARKET ANALYSIS BY DEVICE |
    65. 6.62 THAILAND MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    66. 6.63 THAILAND MARKET ANALYSIS BY USAGE PATTERN |
    67. 6.64 THAILAND MARKET ANALYSIS BY SITE OF DELIVERY |
    68. 6.65 INDONESIA MARKET ANALYSIS BY DEVICE |
    69. 6.66 INDONESIA MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    70. 6.67 INDONESIA MARKET ANALYSIS BY USAGE PATTERN |
    71. 6.68 INDONESIA MARKET ANALYSIS BY SITE OF DELIVERY |
    72. 6.69 REST OF APAC MARKET ANALYSIS BY DEVICE |
    73. 6.70 REST OF APAC MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    74. 6.71 REST OF APAC MARKET ANALYSIS BY USAGE PATTERN |
    75. 6.72 REST OF APAC MARKET ANALYSIS BY SITE OF DELIVERY |
    76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
    77. 6.74 BRAZIL MARKET ANALYSIS BY DEVICE |
    78. 6.75 BRAZIL MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    79. 6.76 BRAZIL MARKET ANALYSIS BY USAGE PATTERN |
    80. 6.77 BRAZIL MARKET ANALYSIS BY SITE OF DELIVERY |
    81. 6.78 MEXICO MARKET ANALYSIS BY DEVICE |
    82. 6.79 MEXICO MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    83. 6.80 MEXICO MARKET ANALYSIS BY USAGE PATTERN |
    84. 6.81 MEXICO MARKET ANALYSIS BY SITE OF DELIVERY |
    85. 6.82 ARGENTINA MARKET ANALYSIS BY DEVICE |
    86. 6.83 ARGENTINA MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    87. 6.84 ARGENTINA MARKET ANALYSIS BY USAGE PATTERN |
    88. 6.85 ARGENTINA MARKET ANALYSIS BY SITE OF DELIVERY |
    89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY DEVICE |
    90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY USAGE PATTERN |
    92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY SITE OF DELIVERY |
    93. 6.90 MEA MARKET ANALYSIS |
    94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY DEVICE |
    95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY USAGE PATTERN |
    97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY SITE OF DELIVERY |
    98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY DEVICE |
    99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY USAGE PATTERN |
    101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY SITE OF DELIVERY |
    102. 6.99 REST OF MEA MARKET ANALYSIS BY DEVICE |
    103. 6.100 REST OF MEA MARKET ANALYSIS BY THERAPEUTIC APPLICATION |
    104. 6.101 REST OF MEA MARKET ANALYSIS BY USAGE PATTERN |
    105. 6.102 REST OF MEA MARKET ANALYSIS BY SITE OF DELIVERY |
    106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
    107. 6.104 RESEARCH PROCESS OF MRFR |
    108. 6.105 DRO ANALYSIS OF HEALTHCARE |
    109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
    112. 6.109 HEALTHCARE, BY DEVICE, 2024 (% SHARE) |
    113. 6.110 HEALTHCARE, BY DEVICE, 2024 TO 2035 (USD Billion) |
    114. 6.111 HEALTHCARE, BY THERAPEUTIC APPLICATION, 2024 (% SHARE) |
    115. 6.112 HEALTHCARE, BY THERAPEUTIC APPLICATION, 2024 TO 2035 (USD Billion) |
    116. 6.113 HEALTHCARE, BY USAGE PATTERN, 2024 (% SHARE) |
    117. 6.114 HEALTHCARE, BY USAGE PATTERN, 2024 TO 2035 (USD Billion) |
    118. 6.115 HEALTHCARE, BY SITE OF DELIVERY, 2024 (% SHARE) |
    119. 6.116 HEALTHCARE, BY SITE OF DELIVERY, 2024 TO 2035 (USD Billion) |
    120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    121. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY DEVICE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY USAGE PATTERN, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY SITE OF DELIVERY, 2025-2035 (USD Billion) |
    151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    152. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Device (USD Billion, 2025-2035)

  • Conventional Injection Devices
  • Self-Injection Devices

Healthcare By Therapeutic Application (USD Billion, 2025-2035)

  • Autoimmune Diseases
  • Hormonal Disorders and Cancer

Healthcare By Usage Pattern (USD Billion, 2025-2035)

  • Curative Pattern
  • Immunization

Healthcare By Site of Delivery (USD Billion, 2025-2035)

  • Intramuscular
  • Subcutaneous
  • Intradermal

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions